KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Other Working Capital Changes (2016 - 2026)

AbbVie has reported Other Working Capital Changes over the past 14 years, most recently at $658.0 million for Q4 2025.

  • Quarterly Other Working Capital Changes rose 558.0% to $658.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $827.0 million through Dec 2025, up 329.09% year-over-year, with the annual reading at $827.0 million for FY2025, 329.09% up from the prior year.
  • Other Working Capital Changes was $658.0 million for Q4 2025 at AbbVie, up from -$88.0 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $658.0 million in Q4 2025 and troughed at -$452.0 million in Q2 2023.
  • The 5-year median for Other Working Capital Changes is $24.5 million (2022), against an average of $55.8 million.
  • Year-over-year, Other Working Capital Changes skyrocketed 3100.0% in 2021 and then tumbled 1384.0% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$265.0 million in 2021, then surged by 176.98% to $204.0 million in 2022, then skyrocketed by 185.29% to $582.0 million in 2023, then crashed by 82.82% to $100.0 million in 2024, then surged by 558.0% to $658.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other Working Capital Changes are $658.0 million (Q4 2025), -$88.0 million (Q3 2025), and -$371.0 million (Q2 2025).